PL1753723T3 - Podstawione pochodne chinoliny jako inhibitory kinezyn mitotycznych - Google Patents
Podstawione pochodne chinoliny jako inhibitory kinezyn mitotycznychInfo
- Publication number
- PL1753723T3 PL1753723T3 PL05752901T PL05752901T PL1753723T3 PL 1753723 T3 PL1753723 T3 PL 1753723T3 PL 05752901 T PL05752901 T PL 05752901T PL 05752901 T PL05752901 T PL 05752901T PL 1753723 T3 PL1753723 T3 PL 1753723T3
- Authority
- PL
- Poland
- Prior art keywords
- substituted quinoline
- quinoline derivatives
- mitotic kinesin
- kinesin inhibitors
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57312004P | 2004-05-21 | 2004-05-21 | |
PCT/US2005/017961 WO2005113507A1 (en) | 2004-05-21 | 2005-05-19 | Substituted quinoline derivatives as mitotic kinesin inhibitors |
EP05752901A EP1753723B1 (en) | 2004-05-21 | 2005-05-19 | Substituted quinoline derivatives as mitotic kinesin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1753723T3 true PL1753723T3 (pl) | 2009-01-30 |
Family
ID=34970815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05752901T PL1753723T3 (pl) | 2004-05-21 | 2005-05-19 | Podstawione pochodne chinoliny jako inhibitory kinezyn mitotycznych |
Country Status (19)
Country | Link |
---|---|
US (2) | US7452996B2 (pl) |
EP (1) | EP1753723B1 (pl) |
JP (1) | JP2008502721A (pl) |
CN (1) | CN1956960A (pl) |
AT (1) | ATE404536T1 (pl) |
AU (1) | AU2005245492A1 (pl) |
BR (1) | BRPI0511433A (pl) |
CA (1) | CA2564215A1 (pl) |
DE (1) | DE602005008953D1 (pl) |
DK (1) | DK1753723T3 (pl) |
ES (1) | ES2311992T3 (pl) |
HR (1) | HRP20080493T3 (pl) |
MX (1) | MXPA06011958A (pl) |
PL (1) | PL1753723T3 (pl) |
PT (1) | PT1753723E (pl) |
RS (1) | RS50670B (pl) |
RU (1) | RU2385867C2 (pl) |
SI (1) | SI1753723T1 (pl) |
WO (1) | WO2005113507A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06011958A (es) * | 2004-05-21 | 2006-12-15 | Chiron Corp | Derivados de quinolina sustituidos como inhibidores de cinesina mitotica. |
RU2447077C2 (ru) | 2004-08-18 | 2012-04-10 | Астразенека Аб | Энантиомеры выбранных конденсированных пиримидинов и их применение для лечения и предотвращения злокачественного новообразования |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
JP2009514900A (ja) * | 2005-11-04 | 2009-04-09 | スミスクライン・ビーチャム・コーポレイション | 血糖降下剤の投与方法 |
EA200970361A1 (ru) | 2006-10-09 | 2010-02-26 | Такеда Фармасьютикал Компани Лимитед | Ингибиторы киназы |
ES2557478T3 (es) * | 2006-11-13 | 2016-01-26 | Novartis Ag | Compuestos de pirazol y triazol como inhibidores de KSP |
NZ577727A (en) * | 2007-01-05 | 2012-03-30 | Novartis Ag | Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) |
FR2940289B1 (fr) * | 2008-12-23 | 2014-09-12 | Biopharmed | Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas |
BR112012025879A2 (pt) * | 2010-04-15 | 2017-11-21 | Novartis Ag | compostos de triazol como inibidores de ksp |
US8748626B2 (en) * | 2010-04-15 | 2014-06-10 | Novartis Ag | Oxazole and thiazole compounds as KSP inhibitors |
ES2705950T3 (es) | 2011-06-03 | 2019-03-27 | Eisai R&D Man Co Ltd | Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib |
RU2486175C2 (ru) * | 2011-09-12 | 2013-06-27 | Закрытое Акционерное Общество "Фарм-Синтез" | Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений |
US9458161B1 (en) | 2011-11-03 | 2016-10-04 | Vanderblit University | TSPO ligands for cancer imaging and treatment |
BR112015003192A2 (pt) * | 2012-08-13 | 2017-08-08 | Array Biopharma Inc | arry-520 para uso no tratamento de câncer em um paciente com baixa aag |
SI3524595T1 (sl) | 2014-08-28 | 2022-10-28 | Eisai R&D Management Co., Ltd. | Derivat kinolina visoke čistosti in postopek njegove proizvodnje |
LT3263106T (lt) | 2015-02-25 | 2024-01-10 | Eisai R&D Management Co., Ltd. | Chinolino darinių kartumo sumažinimo būdas |
KR20240064733A (ko) | 2015-03-04 | 2024-05-13 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합 |
CA2988707C (en) | 2015-06-16 | 2023-10-10 | Eisai R&D Management Co., Ltd. | Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer |
MX2018001439A (es) * | 2015-08-19 | 2018-05-28 | Eisai R&D Man Co Ltd | Agente terapeutico para cancer de tracto biliar. |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6172087B1 (en) * | 1998-06-03 | 2001-01-09 | Gpi Nil Holding, Inc. | N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
EP1165519A1 (en) | 1999-04-02 | 2002-01-02 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
JP2003512461A (ja) | 1999-10-27 | 2003-04-02 | サイトキネティクス・インコーポレーテッド | キナゾリノンを用いた方法並びに組成 |
US6545004B1 (en) * | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
EP1322620A1 (en) | 2000-10-06 | 2003-07-02 | Neurogen Corporation | Benzimidazole and indole derivatives as crf receptor modulators |
CZ20031910A3 (cs) | 2000-12-11 | 2003-12-17 | Tularik Inc. | Sloučenina s antagonistickými účinky na CXCR3 a farmaceutický postředek |
WO2002057244A1 (en) | 2001-01-19 | 2002-07-25 | Cytokinetics, Inc. | Phenothiazine kinesin inhibitors |
WO2002056880A1 (en) | 2001-01-19 | 2002-07-25 | Cytokinetics, Inc. | Triphenylmethane kinesin inhibitors |
WO2003039460A2 (en) | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
AU2002346471A1 (en) | 2001-11-20 | 2003-06-10 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
WO2003049678A2 (en) | 2001-12-06 | 2003-06-19 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
EP1463733B1 (en) | 2001-12-06 | 2007-09-05 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
US7262186B2 (en) | 2001-12-06 | 2007-08-28 | Merck & Co., Inc. | Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor |
EP1481077B1 (en) | 2001-12-06 | 2009-11-04 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
AU2002364128B2 (en) | 2001-12-06 | 2008-03-06 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
CA2472470A1 (en) | 2002-01-10 | 2003-07-24 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
AU2003213092A1 (en) | 2002-02-15 | 2003-09-09 | Smithkline Beecham Corporation | Syntheses of quinazolinones |
DE60329990D1 (de) | 2002-03-08 | 2009-12-24 | Merck & Co Inc | Mitotische kinesin-hemmer |
NZ536190A (en) | 2002-04-17 | 2007-08-31 | Cytokinetics Inc | Compounds for treating cellular proliferative diseases by modulating the activity of the mitotic kinesin KSP |
US7214800B2 (en) | 2002-05-09 | 2007-05-08 | Cytokinetics, Inc. | Compounds, compositions, and methods |
AU2003223786A1 (en) | 2002-05-09 | 2003-11-11 | Cytokinetics, Inc. | Compounds, methods and compositions |
WO2003103575A2 (en) | 2002-05-23 | 2003-12-18 | Cytokinetics, Inc. | Compounds, compositions, and methods |
AU2003231799A1 (en) | 2002-05-23 | 2003-12-12 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
CA2486215A1 (en) | 2002-06-14 | 2003-12-24 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
WO2003106426A1 (en) | 2002-06-14 | 2003-12-24 | Cytokinetics, Inc. | Compounds, compositions, and methods |
AU2003245453B2 (en) | 2002-06-14 | 2008-08-14 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
CA2489562A1 (en) | 2002-07-08 | 2004-01-15 | Merck & Co., Inc. | Mitotic kinesin binding site |
EP1539727B1 (en) | 2002-07-17 | 2009-02-18 | Cytokinetics, Inc. | Compounds, compositions, and methods for treating cellular proliferative diseases |
JP2006501201A (ja) | 2002-07-23 | 2006-01-12 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
US20040048853A1 (en) | 2002-08-21 | 2004-03-11 | Gustave Bergnes | Compounds, compositions, and methods |
JP2005539062A (ja) | 2002-09-13 | 2005-12-22 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
MXPA06011958A (es) * | 2004-05-21 | 2006-12-15 | Chiron Corp | Derivados de quinolina sustituidos como inhibidores de cinesina mitotica. |
-
2005
- 2005-05-19 MX MXPA06011958A patent/MXPA06011958A/es active IP Right Grant
- 2005-05-19 ES ES05752901T patent/ES2311992T3/es active Active
- 2005-05-19 CA CA002564215A patent/CA2564215A1/en not_active Abandoned
- 2005-05-19 DK DK05752901T patent/DK1753723T3/da active
- 2005-05-19 SI SI200530384T patent/SI1753723T1/sl unknown
- 2005-05-19 AU AU2005245492A patent/AU2005245492A1/en not_active Abandoned
- 2005-05-19 BR BRPI0511433-0A patent/BRPI0511433A/pt not_active IP Right Cessation
- 2005-05-19 EP EP05752901A patent/EP1753723B1/en active Active
- 2005-05-19 PL PL05752901T patent/PL1753723T3/pl unknown
- 2005-05-19 JP JP2007527522A patent/JP2008502721A/ja active Pending
- 2005-05-19 US US11/133,509 patent/US7452996B2/en not_active Expired - Fee Related
- 2005-05-19 DE DE602005008953T patent/DE602005008953D1/de active Active
- 2005-05-19 CN CNA2005800164405A patent/CN1956960A/zh active Pending
- 2005-05-19 PT PT05752901T patent/PT1753723E/pt unknown
- 2005-05-19 RU RU2006145336/04A patent/RU2385867C2/ru not_active IP Right Cessation
- 2005-05-19 RS RSP-2008/0534A patent/RS50670B/sr unknown
- 2005-05-19 AT AT05752901T patent/ATE404536T1/de not_active IP Right Cessation
- 2005-05-19 WO PCT/US2005/017961 patent/WO2005113507A1/en active Application Filing
-
2008
- 2008-09-30 US US12/242,360 patent/US20090028858A1/en not_active Abandoned
- 2008-10-01 HR HR20080493T patent/HRP20080493T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE404536T1 (de) | 2008-08-15 |
RU2006145336A (ru) | 2008-06-27 |
CA2564215A1 (en) | 2005-12-01 |
MXPA06011958A (es) | 2006-12-15 |
BRPI0511433A (pt) | 2007-12-11 |
RS50670B (sr) | 2010-06-30 |
DE602005008953D1 (de) | 2008-09-25 |
CN1956960A (zh) | 2007-05-02 |
DK1753723T3 (da) | 2008-10-20 |
RU2385867C2 (ru) | 2010-04-10 |
ES2311992T3 (es) | 2009-02-16 |
US20050261337A1 (en) | 2005-11-24 |
EP1753723B1 (en) | 2008-08-13 |
US7452996B2 (en) | 2008-11-18 |
US20090028858A1 (en) | 2009-01-29 |
HRP20080493T3 (en) | 2009-02-28 |
JP2008502721A (ja) | 2008-01-31 |
WO2005113507A1 (en) | 2005-12-01 |
PT1753723E (pt) | 2008-11-19 |
SI1753723T1 (sl) | 2009-04-30 |
EP1753723A1 (en) | 2007-02-21 |
AU2005245492A1 (en) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1753723E (pt) | Derivados de quinolina substituída como inibidores de quinesina mitótica | |
TW200612958A (en) | Substituted imidazole derivatives | |
MX2007004699A (es) | Derivados de indol y bencimidazol. | |
TW200800951A (en) | Substituted imidazole compounds as KSP inhibitors | |
MX2009007260A (es) | Derivados de imidazol como inhibidores de proteina de huso de cinesina (eg-5). | |
TW200801000A (en) | Spiroindolinone derivatives | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
WO2011058474A8 (en) | N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
MX2012009186A (es) | Pirrolidina-2-carboxamidas sustituidas. | |
TW200728307A (en) | Novel spirochromanone derivatives | |
HK1154002A1 (en) | Imidazopyridazinecarbonitriles useful as kinase inhibitors | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
HK1133596A1 (en) | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme | |
TW200833675A (en) | Nicotinamide derivatives | |
MX2011013771A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
MX2009006756A (es) | Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv. | |
MX2013004733A (es) | Inhibidores de n1/n2-lactama acetil-coa carboxilasa. | |
MX2012003982A (es) | Pirrolidinas n-substituidas. | |
UA97256C2 (ru) | Замещенные пиразолы и триазолы как ингибиторы кбв (кинезин-белок веретена) | |
TN2009000049A1 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
IL193620A0 (en) | Spiroindolinone derivatives | |
MX2009009238A (es) | Nuevos inhibidores de fosfodiesterasa. | |
MX2011008176A (es) | Derivados de 3,3'-espiroindolinona como agentes anticancerigenos. | |
IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same |